{"beta":true,"receipt":{"kind":"unpaid_probe","ts":"2026-10-24T17:24:22Z","host":"clinicalintelpulse.vercel.app","url":"https://clinicalintelpulse.vercel.app/api/clinical/deal-signal","method":"GET","status":402,"latency_ms":549,"error":null,"req_sha256":"791d9d2cbee5ea17f395a13593b4ae459050dc548a2ea87e8da090d57734fdf3","resp_sha256":"7ebec1e80e81aff15524ef05c86b0fa4153277bf89aa7b36719a6c9bd1d61309","total_header_bytes":13519,"prober_ua":"BotsRated-probe/0.3 (unpaid check; no payment sent; +https://botsrated.com/disputes)","prober":"botsrated-prober (Cloudflare cron)","probe_version":"0.3","scope":"primary","x402_version":2,"payment_required_header_bytes":12800,"valid_402":true,"live_amount":"350000","live_payTo":"0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc","live_asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","live_network":"eip155:8453","checks":{"terms_consistent":false,"terms_issues":["header_body_terms_differ","option_amount_not_integer","resource_host_differs"],"options":13,"base_usdc":true,"payto_stable":true},"resource_description":"Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.","extensions_advertised":["bazaar","reconciliation","builder-code"],"payment_identifier":{"advertised":false,"required":false},"id":"f7e8439a29403c3c9d65","sig":{"alg":"ed25519","key_id":"botsrated-prober-1","signed":"canonical JSON of this receipt without the sig field (keys sorted, no whitespace)","sig_b64":"ujxtRQKoTpr3m8JB11AsD3WhtgDWDHvh7gucieoAAbdP7Wio5++J88066/FARy1SErLQh7bi192df8VJC9vABg=="},"receipt_url":"https://botsrated.com/receipt/f7e8439a29403c3c9d65?host=clinicalintelpulse.vercel.app&day=2026-10-24","tx_url":null,"payment":"none (unpaid probe; no payment header was sent)","signature":"ed25519 per-receipt signature (key botsrated-prober-1; see /.well-known/botsrated-key)"},"stored_in":"D1"}